Evidence map›Paper›PMID 30043237›Full record

ArticleRheumatology international2018

Activity of rheumatoid arthritis correlates with oral inflammatory burden.

Leena Äyräväinen, Anna Maria Heikkinen, Antti Kuuliala, Kirsi Ahola, Riitta Koivuniemi, Jaakko Peltola, Anni Suomalainen, Eeva Moilanen, Mari Hämäläinen, Leena Laasonen and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Leena ÄyräväinenDepartment of Oral and Maxillofacial Diseases, Helsinki University Hospital, University of Helsinki, Haartmaninkatu 8, PO Box 63, 00014, Helsinki, Finland. leena.ayravainen@helsinki.fi.ORCID http://orcid.org/0000-0001-6041-3593
Anna Maria HeikkinenDepartment of Oral and Maxillofacial Diseases, Helsinki University Hospital, University of Helsinki, Haartmaninkatu 8, PO Box 63, 00014, Helsinki, Finland.ORCID http://orcid.org/0000-0003-3252-192X
Antti KuulialaDepartment of Bacteriology and Immunology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-3190-207X
Kirsi AholaDepartment of Oral and Maxillofacial Diseases, Helsinki University Hospital, University of Helsinki, Haartmaninkatu 8, PO Box 63, 00014, Helsinki, Finland.
Riitta KoivuniemiDepartment of Rheumatology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Jaakko PeltolaDepartment of Radiology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Anni SuomalainenDepartment of Radiology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Eeva MoilanenThe Immunopharmacology Research Group, Tampere University Hospital, University of Tampere School of Medicine, Tampere, Finland.ORCID http://orcid.org/0000-0003-1284-3008
Mari HämäläinenThe Immunopharmacology Research Group, Tampere University Hospital, University of Tampere School of Medicine, Tampere, Finland.ORCID http://orcid.org/0000-0002-6409-3758
Leena LaasonenDepartment of Radiology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Jukka H MeurmanDepartment of Oral and Maxillofacial Diseases, Helsinki University Hospital, University of Helsinki, Haartmaninkatu 8, PO Box 63, 00014, Helsinki, Finland.ORCID http://orcid.org/0000-0001-6702-6836
Marjatta Leirisalo-RepoDepartment of Rheumatology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-1568-9045

Funding

Helsinki University Hospital Research Funds TYH2008232Helsinki University Hospital Research Funds TYH2011115Helsinki University Hospital Research Funds TYH2013328Helsinki University Hospital Research Funds TYH2014225Helsinki University Hospital Research Funds TYH2015119Helsinki University Hospital Research Funds TYH5231
6 · The paper itself

Abstract

To study oral health in patients with rheumatoid arthritis (RA) with emphasis on disease activity and treatment of RA. In this prospective cohort study 81 RA patients [53 early untreated RA (EURA) and 28 chronic RA (CRA) patients with inadequate response to synthetic disease modifying antirheumatic drugs (DMARDs)], underwent rheumatological [Disease Activity Score (28-joint) DAS28] and dental examinations [Total Dental Index (TDI), Decayed Missing Filled Teeth (DMFT) and Decayed Missing Filled Surfaces (DMFS)]. For controls, 43 volunteers were examined. After the examinations, EURA patients started treatment with synthetic DMARDs, oral and intra-articular glucocorticoids. CRA patients were candidates for biological DMARDs. The patients were re-examined mean 16 months later. Results were analyzed with descriptive statistics and logistic regression. TDI was higher in both RA groups at baseline compared to controls [EURA: 2 (2-3); CRA: 2 (1-3); controls 1 (1-3), p = 0.045]. DMFT [r

Indexed as

Oral HealthAdultAgedAged, 80 and overAntirheumatic AgentsArthritis, RheumatoidBiological ProductsDental CariesFemaleFinlandGlucocorticoidsHumansMaleMiddle AgedProspective StudiesSeverity of Illness IndexAntirheumatic AgentsBiological ProductsGlucocorticoidsAntirheumatic agentsArthritis, rheumatoidOral health

Identifiers

PMID30043237

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.